Requests that the FDA remove all octocrylene products from the marketplace based on human health risks associated with the unavoidable presences of the carcinogenic benzophenone.
🏛 Food and Drug Administration (FDA)FDA-2021-P-0508
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.